IP Library Granted Patent US 9,545,433
Granted Patent B2
US 9,545,433 · App. 14/952,075 · Granted Jan 17, 2017

Myonectin (CTRP15), compositions comprising same, and methods of use

Inventors: Guang William Wong (Lutherville, MD); Marcus Michael Seldin (Baltimore, MD)
Assignee: The Johns Hopkins University
A61K38/19A61K38/1709C07K14/47C07K14/52C07K14/775C07K16/24A61K38/00C07K2317/76
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,545,433
App. No.
14/952,075
Granted
Jan 17, 2017
Kind
B2
Abstract

Disclosed is the novel myokine known as myonectin (CTRP15), an isolated nucleic acid encoding the myonectin (CTRP15) gene, and the amino acid sequence encoding the myonectin (CTRP15) protein. Methods of isolation of the nucleic acid, protein, polypeptides and methods of making anybodies to myonectin (CTRP15) protein are provided. The use of myonectin (CTRP15) in the modulation of lipid and/or glucose metabolism, suppressing the expression of autophagy genes, inhibiting LC3 lipidation and autophagosome-dependent p62 degradation, and activating the Akt/mTOR pathway is also provided.

Claims (10)

1. A method of suppressing the expression of autophagy genes in a subject selected from the group consisting of Atg5, Atg7 and Atg12, comprising administering to the subject an effective amount of C1q tumor necrosis factor (TNF) related protein 15 (CTRP15) myonectin protein, or a functional portion thereof, and a pharmaceutically acceptable carrier, wherein the functional portion is the C1q/TNF-like domain of the CTRP 15 myonectin protein.

2. The method of claim 1 , wherein the autophagy gene that is suppressed is Atg5.

3. The method of claim 1 , wherein the autophagy gene that is suppressed is Atg7.

4. The method of claim 1 , wherein the autophagy gene that is suppressed is Atg12.

5. The method of claim 1 , wherein the CTRP 15 myonectin protein is in the form of a recombinant expression vector comprising the nucleotide sequence of SEQ ID NO: 1.

6. The method of claim 5 , wherein the autophagy gene that is suppressed is Atg7.

7. The method of claim 5 , wherein the autophagy gene that is suppressed is Atg12.

8. The method of claim 1 , wherein the C1q/TNF-like domain of the CTRP 15 myonectin protein is in the form of a recombinant expression vector comprising the nucleotide sequence of SEQ ID NO: 1 which encodes the C1q/TNF-like domain.

9. The method of claim 8 , wherein the autophagy gene that is suppressed is Atg7.

10. The method of claim 8 , wherein the autophagy gene that is suppressed is Atg12.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 25, 2018
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045143/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2016
From: WONG, GUANG WILLIAM; SELDIN, MARCUS MICHAEL
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 040328/0673 →
Continuity (3)
Division 14373685
Provisional Application 61590940 · Jan 26, 2012
Related Publication 20160143994A1 · May 26, 2016